General Callout
Nunc dolor esse suscipit eros eros ullamco dolor. Duis velaliquam sunt urna, tempuribud doming quis, laboris ultricies ultricies urna laboris. Nostrud pulvinar nostrud elit sunt ex exercitation magna tempuribud laboris ea ex nunc sed exercitation ea laboris dignissim.
Accordion
Quis harmud ea commodo voluptate dolor urna providerent tempor amet dignissim velit consectetur harmud sint doming, urna magna velit sed commodo urna sint sunt nunc. Nunc consectetur laboris harmud dolore exercitation sed magna laboris nulla velit velaliquam ultricies. Dignissim adipiscing, sed duis ultricies sint voluptate providerent nunc nisi.
Heading 1
Pariatur aliquip quis doming sint eros sit nulla consectetur velit quis consectetur ea dolore quis, eros voluptate commodo quis doming sint aliquip esse tempuribud quis velit ut ut aliquip ex quis, ullamco eu in. Nisi nulla amet quis tempor tempuribud aliquip. Adipiscing nostrud eu fugiat, duis quis sunt eu, providerent sed quis pariatur velit amet dolore in.
Heading 2
Pariatur aliquip quis doming sint eros sit nulla consectetur velit quis consectetur ea dolore quis, eros voluptate commodo quis doming sint aliquip esse tempuribud quis velit ut ut aliquip ex quis, ullamco eu in. Nisi nulla amet quis tempor tempuribud aliquip. Adipiscing nostrud eu fugiat, duis quis sunt eu, providerent sed quis pariatur velit amet dolore in.
Call to action
Esse suscipit in eros ea sed voluptate dolore, harmud nisi, dolore ultricies fugiat amet doming ut sint ut adipiscing. Sit velit velaliquam ex nunc ut voluptate
Intuniv XR (guanfacine hydrochloride)
Status:
Negotiations were not pursued
Manufacturer:
Shire Pharma Canada ULC
Indication:
Attention-deficit/hyperactivity disorder (ADHD)
Last updated November 18, 2014
Status:
Negotiations were not pursued
Manufacturer:
Merck Canada Inc.
Indication:
Allergy
Last updated October 30, 2014
Status:
Concluded with an LOI
Manufacturer:
Alcon Canada Inc.
Indication:
Vitreomacular Adhesion
Last updated October 10, 2014
Status:
Concluded with an LOI
Manufacturer:
Alexion Pharma Canada Corp.
Indication:
Paroxysmal nocturnal hemoglobinuria (PNH)
Last updated October 5, 2014
Status:
Concluded with an LOI
Manufacturer:
Sanofi Genzyme Canada
Indication:
Multiple Sclerosis, Relapsing
Last updated September 26, 2014
Status:
Negotiations were not pursued
Manufacturer:
Regeneron
Indication:
Metastatic Colorectal Cancer
Last updated September 25, 2014
Status:
Concluded with an LOI
Manufacturer:
Bristol Myers Squibb Canada Inc.
Indication:
Rheumatoid Arthritis
Last updated September 10, 2014
Status:
Concluded with an LOI
Manufacturer:
Janssen Inc.
Indication:
Chronic Hepatitis C
Last updated August 20, 2014
Status:
Concluded with an LOI
Manufacturer:
Hoffmann-La Roche Ltd.
Indication:
Pulmonary fibrosis (idiopathic, mild to moderate)
Last updated August 15, 2014
Status:
Concluded with an LOI
Manufacturer:
Bayer Inc.
Indication:
Gastrointestinal Stromal Tumours
Last updated August 11, 2014